Character | Response | |
---|---|---|
|
|
|
|
|
|
Character | Response | |
---|---|---|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Class | Active | Resistant |
---|---|---|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Lineage | Physiology | General | Growth Tolerances | Hydrol./digest./degr. |
|
|
Health: Unknown
Source: lymph nodes and is associated with Hodgkin's disease
DNA G+C(%): 53-54
|
|
|
---|
Monosaccharide O/F | Oligosaccharide O/F | Polysaccharide O/F | Polyol O/F | Other O/F |
|
|
|
|
|
---|
Enzymes: General | Enzymes: Carbohydrate | Enzymes: Protein | Enzymes: Arylamidases | Enzymes: Esters/fats |
|
|
|
|
|
---|
Fuel | Usable Metabolites | Metabolites Released | Special Products | Compounds Produced |
|
---|
Penicillins & Penems (μg/mL) | Cephalosporins (μg/mL) | Aminoglycosides (μg/mL) | Macrolides (μg/mL) | Quinolones (μg/mL) |
penicillin_G: S(MIC50): 0.03, MIC90: 0.25, RNG: (≤0.015–0.5)
|
|
|
azithromycin: S(MIC50): 0.06, MIC90: 0.25, RNG: (0.03–>32)
erythromycin: S(MIC50): 0.06, MIC90: 0.25, RNG: (0.03–.128)
|
levofloxacin: S(MIC50): 0.25, MIC90: 0.5, RNG: (0.125–1)
moxifloxacin: S(MIC50): 0.25, MIC90: 0.5, RNG: (0.06–1)
|
---|---|---|---|---|
Tetracyclines (μg/mL) | Vancomycin Class (μg/mL) | Polypep/ketides (μg/mL) | Heterocycles (μg/mL) | Other (μg/mL) |
doxycycline: S(MIC50): 0.25, MIC90: 0.5, RNG: (0.06–1)
minocycline: S(MIC50): 0.125, MIC90: 0.25, RNG: (0.06–1)
tetracycline: S(MIC50): 1, MIC90: 2, RNG: (0.5–4)
|
vancomycin: S(MIC50): 0.5, MIC90: 1, RNG: (0.25–1)
|
|
|
|